Oncology Companion Diagnostic Market Hits New High | Major Giants Sophia Genetics, ArcherDx, Foundation Medicine

HTF MI recently introduced Global Oncology Companion Diagnostic Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market size (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence.

Major Companies in Oncology Companion Diagnostic Market are: Roche (Switzerland), Agilent (USA), Thermo Fisher (USA), Qiagen (Germany), Illumina (USA), Abbott (USA), Danaher (USA), Guardant Health (USA), Foundation Medicine (USA), Bio-Rad (USA), Sysmex (Japan), Hologic (USA), BGI Genomics (China), ArcherDx (USA), Genetron (China), Myriad Genetics (USA), Invitae (USA), Seagen (USA), AmoyDx (China), Genetron Health (China), Natera (USA), Sophia Genetics (Switzerland), ArcherDx (USA), Burning Rock Dx (China), ArcherDx (USA),others

Get inside Scoop of Oncology Companion Diagnostic Market:
👉 https://www.htfmarketintelligence.com/sample-report/global-oncology-companion-diagnostic-market?utm_source=Umang_OpenPR&utm_id=Umang

HTF Market Intelligence projects that the global Oncology Companion Diagnostic market will expand at a compound annual growth rate (CAGR) of 12.1% from 2025 to 2032, from 9.8 Billion in 2025 to 24.6 Billion by 2032.

Our Report Covers the Following Important Topics:
By Type
PCR-based, NGS-based, IHC-based, FISH-based, Liquid biopsy

By Application
Lung cancer, Breast cancer, Colorectal cancer, Leukemia, Prostate cancer

Definition:
The oncology companion diagnostic market comprises the global commercial landscape for diagnostic tests and related technologies that are specifically developed and approved to guide the use of targeted cancer therapies. These diagnostics are designed to identify genetic, molecular, or protein biomarkers in tumor tissue or bodily fluids, enabling clinicians to determine which patients are most likely to benefit from a particular oncology drug or are at risk of adverse reactions. The market includes assay kits, reagents, instruments, software, and associated testing services used across clinical laboratories, hospitals, and research settings. By directly linking diagnostic results with therapeutic decision-making, this market plays a critical role in advancing precision oncology, improving treatment outcomes, and optimizing personalized cancer care.
Market Trends
• Liquid biopsy growth, AI-assisted genomics, NGS panel expansion, pharma-diagnostic partnerships, decentralized testing dominate trends.

Market Drivers:
• Precision medicine adoption, targeted cancer therapies, biomarker-driven drug approvals, rising cancer prevalence, and regulatory support for CDx development are key drivers.

Market Challenges:
• High development costs, regulatory complexity, reimbursement variability, data interpretation challenges, limited access in low-income regions.

Dominating_Region :
North America

FastestGrowing_Region:
Asia-Pacific

Have a query? Market an enquiry before purchase 👉 👉 https://www.htfmarketintelligence.com/enquiry-before-buy/global-oncology-companion-diagnostic-market?utm_source=Umang_OpenPR&utm_id=Umang

The titled segments and sub-section of the market are illuminated below:
In-depth analysis of Oncology Companion Diagnostic market segments by Types: PCR-based, NGS-based, IHC-based, FISH-based, Liquid biopsy
Detailed analysis of Oncology Companion Diagnostic market segments by Applications: Lung cancer, Breast cancer, Colorectal cancer, Leukemia, Prostate cancer

Global Oncology Companion Diagnostic Market -Regional Analysis
• North America: United States of America (US), Canada, and Mexico.
• South & Central America: Argentina, Chile, Colombia, and Brazil.
• Middle East & Africa: Kingdom of Saudi Arabia, United Arab Emirates, Turkey, Israel, Egypt, and South Africa.
• Europe: the UK, France, Italy, Germany, Spain, Nordics, BALTIC Countries, Russia, Austria, and the Rest of Europe.
• Asia: India, China, Japan, South Korea, Taiwan, Southeast Asia (Singapore, Thailand, Malaysia, Indonesia, Philippines & Vietnam, etc) & Rest
• Oceania: Australia & New Zealand

Oncology Companion Diagnostic Market Research Objectives:
- Focuses on the key manufacturers, to define, pronounce and examine the value, sales volume, market share, market competition landscape, SWOT analysis, and development plans in the next few years.
- To share comprehensive information about the key factors influencing the growth of the market (opportunities, drivers, growth potential, industry-specific challenges and risks).
- To analyze the with respect to individual future prospects, growth trends and their involvement to the total market.
- To analyze reasonable developments such as agreements, expansions new product launches, and acquisitions in the market.
- To deliberately profile the key players and systematically examine their growth strategies.

Buy Now Latest Edition of Oncology Companion Diagnostic Market Report https://www.htfmarketintelligence.com/buy-now?format=1&report=22680-global-oncology-companion-diagnostic-market?utm_source=Umang_OpenPR&utm_id=Umang

FIVE FORCES & PESTLE ANALYSIS:
In order to better understand market conditions five forces analysis is conducted that includes the Bargaining power of buyers, Bargaining power of suppliers, Threat of new entrants, Threat of substitutes, and Threat of rivalry.
• Political (Political policy and stability as well as trade, fiscal, and taxation policies)
• Economical (Interest rates, employment or unemployment rates, raw material costs, and foreign exchange rates)
• Social (Changing family demographics, education levels, cultural trends, attitude changes, and changes in lifestyles)
• Technological (Changes in digital or mobile technology, automation, research, and development)
• Legal (Employment legislation, consumer law, health, and safety, international as well as trade regulation and restrictions)
• Environmental (Climate, recycling procedures, carbon footprint, waste disposal, and sustainability)

Points Covered in Table of Content of Global Oncology Companion Diagnostic Market:

Chapter 01 - Oncology Companion Diagnostic Executive Summary
Chapter 02 - Market Overview
Chapter 03 - Key Success Factors
Chapter 04 - Global Oncology Companion Diagnostic Market - Pricing Analysis
Chapter 05 - Global Oncology Companion Diagnostic Market Background or History
Chapter 06 - Global Oncology Companion Diagnostic Market Segmentation (e.g. Type, Application)
Chapter 07 - Key and Emerging Countries Analysis Worldwide Oncology Companion Diagnostic Market
Chapter 08 - Global Oncology Companion Diagnostic Market Structure & worth Analysis
Chapter 09 - Global Oncology Companion Diagnostic Market Competitive Analysis & Challenges
Chapter 10 - Assumptions and Acronyms
Chapter 11 - Oncology Companion Diagnostic Market Research Method

Thanks for reading this article; you can also get individual chapter-wise sections or region-wise report versions like North America, MINT, BRICS, G7, Western / Eastern Europe, or Southeast Asia. Also, we can serve you with customized research services as HTF MI holds a database repository that includes public organizations and Millions of Privately held companies with expertise across various Industry domains.

Nidhi Bhawsar (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Phone: +15075562445
sales@htfmarketreport.com

About Author:
HTF Market Intelligence Consulting is uniquely positioned to empower and inspire with research and consulting services to empower businesses with growth strategies, by offering services with extraordinary depth and breadth of thought leadership, research, tools, events, and experience that assist in decision-making.

This release was published on openPR.